Why the study?
Does maternal HbA1 level correlate with newborn ventricular septal thickness in infants of well-controlled diabetic mothers?
Does maternal HbA1 level correlate with newborn ventricular septal thickness in infants of well-controlled diabetic mothers?
In infants of well-controlled diabetic mothers, echocardiographic evidence of hypertrophic cardiomyopathy is common but does not correlate with third-trimester maternal HbA1 levels.
Answers are grounded in this paper and cite their sources.
Septal thickening is common yet unrelated to maternal HbA1c in these infants; leaves open non-glycemic mechanisms and prospective validation.
Hypertrophic cardiomyopathy has been well documented in infants of diabetic mothers (IDMs). If this asymmetric septal enlargement is an anabolic result of fetal hyperinsulinemia triggered by maternal hyperglycemia during the third trimester, maternal glycosylated hemoglobin (HbA1) levels, an indicator of glycemic control, should then correlate positively at delivery with newborn ventricular septal thickness. In this study of 20 infants of well-controlled diabetic mothers, no relationship was observed between echocardiographic evidence of hypertrophic cardiomyopathy and maternal HbA1 levels. Seven babies (35%) exhibited exaggerated septal thickening, but none had cardiac-specific symptoms. Although 60 percent of the IDMs were large for gestational age and 45 percent demonstrated neonatal hypoglycemia, neither of these complications correlated with maternal HbA1. In this group of babies of well-controlled diabetic women, echocardiographic indicators of cardiomyopathy were common, but clinical evidence of cardiac embarrassment was not observed. Moreover, these data do not support third trimester maternal hyperglycemia as instrumental in the etiology of cardiomyopathy and other complications of IDMs.
No takes yet. Share an insight, caveat, or question.
Sheehan et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: